SLDB
Solid Biosciences LLC
8.90$
+4.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | -44.3% | +277.7% | -67.2% | +20.5% | -16.6% | -219.9% | – | -107.4% | – | – | – | |
| – | +19.3% | -16.9% | +29.9% | +43.2% | +27.6% | -12.6% | -5.9% | +24.9% | +65.5% | -20.7% | +9.0% | – | |
| – | -252.5% | – | – | +3,535.9% | -24.9% | -15.8% | -241.6% | – | -284.7% | – | -219.6% | – | |
| – | -76.5% | +65.6% | +91.9% | -94.8% | +1,260.0% | -38.2% | +199.2% | -77.5% | +564.7% | -70.8% | -9.1% | – | |
| – | – | -185.0% | -86.6% | +112.3% | – | -171.2% | +19.2% | +38.3% | – | -4.8% | -398.5% | – | |
| – | -300.0% | +2,992.9% | – | -205.9% | -100.0% | – | +8,205.0% | -100.0% | – | – | – | – | |
| – | – | – | – | – | +6.7% | +5.5% | +5.2% | +71.1% | -16.5% | -100.0% | – | – | |
| – | -80.7% | +21,135.8% | -95.3% | -34.9% | +113.1% | +2,633.8% | -100.8% | – | +337.3% | +4,547.6% | -79.7% | – | |
| – | – | +74.4% | -149.9% | – | – | +722.2% | -155.0% | – | – | – | -158.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.